Skip to main content
. 2009 Jul 2;100(10):1931–1934. doi: 10.1111/j.1349-7006.2009.01273.x

Figure 2.

Figure 2

Kaplan–Meier plot of survival times stratified by the cumulative smoking dose (13 pack‐years [PY]). (a) Overall survival of patients treated with gefitinib. (b) Progression‐free survival of patients treated gefitinib. MPFS, median progression‐free survival time; MST, median survival time. P‐values were calculated using the log‐rank test.